Answer
Co-administration of dabigatran etexilate with a single 200 mg dose of abrocitinib (Cibinqo) increased dabigatran AUCinf and Cmax by approximately 53% and 40%, respectively, so concomitant use requires caution.
Sources for this answer
- Cibinqo 200 mg film-coated tabletsPfizer Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 14Document updated
Sources checked